Glenn Batchelder
InvestorVenture Partner at Pivotal Life Sciences
Cambridge, Massachusetts
Writes $100K β $5M checks Β· typically $1.5M
About
Glenn Batchelder is a biotech executive with over 30 years of leadership experience across operations, sales, marketing, business development, manufacturing, supply chain, and R&D. He co-founded and served as CEO of Civitas Therapeutics (acquired by Acorda Therapeutics), and previously led BIND Therapeutics (acquired by Pfizer) and Acceleron Pharma (acquired by Merck), after beginning his career at Millennium Pharmaceutical. He holds a BS in Chemical Engineering from Lehigh University.
Invests in
BiotechHealthtechMedical Devices
Experience
- Pivotal bioVenture PartnersVenture Partnercurrent2022 β present
- Synchronicity PharmaChairmancurrent2017 β present
- XyloCor TherapeuticsChairmancurrent2016 β present
- The Michael J. Fox Foundation for Parkinson's ResearchMember Board of Directorscurrent2015 β present
- Kantum BioChairman2018 β 2022
- The Possible ProjectMember Board of Directors2015 β 2021Cambridge, MA
- SynspiraMember Board Of Directors2017 β 2019
- MassBioMember Board of Directors2003 β 2018
- MassBioChairman of the Board of Directors2014 β 2016
- Civitas Therapeutics (acquired by Acorda Therapeutics 10/2014)Board Member2014
- Civitas Therapeutics (acquired by Acorda Therapeutics 10/2014)President, CEO, Founder and Board Member2009 β 2014
- BIND Therapeutics (Acquired by Pfizer 6/2016)President and CEO2007 β 2009
- Acceleron Pharma (Acquired by Merck 11/2021)President & CEO2004 β 2006
- Millennium Pharmaceuticals (Acquired by Takeda 5/2008)SVP Operations2003 β 2004
- Millennium PharmaceuticalsVP Operations1999 β 2003
Education
- Lehigh UniversityBachelor's Degree, Chemical Engineering1979 β 1983
Skills & more
+5 more
Regulatory AffairsClinical TrialsLife SciencesMedical DevicesDrug DiscoveryFrom Glenn's professional profile.
Same school
Also attended Lehigh University56
+ 50 more
Shared employers
Also worked at Pivotal bioVenture Partners7
+ 1 more
Also worked at The Possible Project1
Also worked at MassBio6
Also worked at Millennium Pharmaceuticals25
+ 19 more
Investments
Board seats
OncXernaSynchronicity PharmaXyloCor Therapeutics
Per the firm's website.





















